• GPR35–KLF5 Circuitry in Colonic Repair

  2026-09-20

  The reference study identifies a tryptophan–kynurenine–kynurenic acid sensing mechanism in which GPR35 converts mucosal damage signals into KLF5-dependent epithelial repair. Its findings connect metabolite surveillance with PI3K–AKT–mTOR signaling and provide a mechanistic framework for interpreting barrier restoration in ulcerative colitis research and DSS-based models.

• PPT: A Decision Framework for ERα Assays

  2026-09-19

  PPT (Propyl Pyrazole Triol) enables precise interrogation of ERα biology without treating receptor activation and cancer-network correlation as equivalent evidence. This article translates a female lung adenocarcinoma biomarker study into practical assay decisions, controls, and interpretation strategies.

• Miransertib and WecA: Designing Clear Assays

  2026-09-18

  Miransertib is best used as an orthogonal AKT-pathway research probe, not as a presumed WecA inhibitor. This article explains how the latest WecA purification and kinetic framework can sharpen target-validation decisions, controls, and assay interpretation.

• IPR-803: Urokinase Receptor Inhibitor Workflow

  2026-09-18

  IPR-803 is a competitive uPAR inhibitor for dissecting uPAR–uPA signaling, tumor invasion, and angiogenesis in breast and pancreatic cancer models. This workflow connects biochemical target engagement with invasion assays and the stromal-remodeling strategy reported for gemcitabine delivery in pancreatic cancer.

• Clozapine N-oxide (CNO) for Circuit Studies

  2026-09-17

  Clozapine N-oxide (CNO) converts engineered receptor expression into reversible, non-invasive neuronal activity modulation. This workflow-focused guide shows how to use CNO in light–anxiety circuit studies, manage ligand preparation, and separate receptor-mediated effects from timing, handling, and behavioral confounds.

• Cy5 NHS ester(Et): Practical Labeling Guide

  2026-09-17

  Cy5 NHS ester(Et) provides a water-compatible way to covalently tag primary amines on proteins, peptides, and related biomolecules for fluorescent detection. It is appropriate for aqueous or DMSO-based labeling workflows, but not for ethanol-based preparation or long-term storage of dissolved reagent.

• Chlorpromazine Workflows for Cellular Research

  2026-09-16

  Build reproducible dopamine D2 receptor signaling, antipsychotic, and antiemetic assays with chlorpromazine hydrochloride while controlling solvent, timing, and cell-context effects. A recent hepatic nanoparticle study adds a practical lesson: cellular heterogeneity and physicochemical context should guide assay design rather than relying on a single presumed clearance pathway.

• Chlorpromazine in Neuropharmacology Assays

  2026-09-16

  Chlorpromazine and chlorpromazine hydrochloride support precise studies of dopamine D2 receptor signaling, antipsychotic pharmacology, and emesis pathways. This guide adds a distinct assay-design perspective by showing how recent liver nanoparticle research can sharpen compartment-specific experimental interpretation without overstating cross-domain evidence.

• H 89 2HCl in Hippocampal PKA Assays

  2026-09-15

  H 89 2HCl is a selective PKA probe for dissecting cAMP/PKA signaling, protein phosphorylation, and neuronal calcium regulation. This guide connects its pharmacology to glucocorticoid-driven Kv2.1–CaV1.2 trafficking and outlines controls that distinguish PKA causality from concentration-dependent off-target effects.

• Rhodamine B: From Spray Drift to Signal Quality

  2026-09-15

  Rhodamine B is more than a fluorescent tracer: it is a measurement tool for connecting spray deposition, matrix effects, and assay quality. This article explains how to use Basic Violet 10 to design better drift studies and interpret fluorescence responsibly across environmental and imaging workflows.

• MALAT1–miR-125b–STAT3 Axis in Sepsis PCT

  2026-09-14

  The reference study identifies a MALAT1–miR-125b–STAT3 regulatory axis that increases procalcitonin expression in sepsis-associated inflammation. Its combination of clinical samples, LPS-stimulated U937 cells, RNA localization, interaction assays, and pathway perturbation provides a mechanistic framework for interpreting PCT elevation, while also highlighting important limits in translating a ceRNA model to patient diagnosis.

• PreScission Protease for Condensate Workflows

  2026-09-14

  PreScission Protease enables sequence-specific fusion protein tag cleavage under low-temperature conditions, an important advantage when studying fragile dKeap1 condensate systems. This guide translates HRV 3C protease chemistry into construct design, purification, and assay-control decisions without overstating what the condensate literature demonstrates.

• A20, Oxidized Self-DNA, and Acute Kidney Injury

  2026-09-13

  The reference study identifies oxidized self-DNA as an upstream driver of acute kidney injury through coordinated cGAS-STING activation and NLRP3 inflammasome-mediated pyroptosis. It further shows that A20 and an A20-derived peptide restrain this process by disrupting the NEK7–NLRP3 interaction, providing a mechanistic basis for targeted anti-inflammatory strategies.

• n-Dodecyl-β-D-maltoside for Integrin Cryo-EM

  2026-09-12

  n-Dodecyl-β-D-maltoside (DDM) offers a gentle route to solubilize and stabilize full-length membrane proteins without treating detergent as a one-size-fits-all additive. This workflow connects DDM selection with integrin cryo-EM, activity preservation, protein–lipid interaction studies, and practical troubleshooting.

• Crizotinib hydrochloride in Gastric Models

  2026-09-11

  Use Crizotinib hydrochloride as a mechanistic ALK kinase inhibitor in matched gastric organoid–stroma assays, not merely as a viability reagent. This workflow connects target phosphorylation, tumor–stroma context, and patient-specific response differences to improve cancer biology research decisions.

510 records 1/34 page Next 12345 下5页 Last page